UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 195

Sortiert nach

Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

Bone marrow transplantation (Basingstoke), 2016-01, Vol.51 (1), p.51-57

2016

Link zum Volltext

Verfügbarkeit prüfen

The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia

Leukemia, 2010-06, Vol.24 (6), p.1152-1159

2010

Link zum Volltext

Verfügbarkeit prüfen

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

Blood, 2023-06, Vol.141 (25), p.3055

2023

Link zum Volltext

Verfügbarkeit prüfen

Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

Leukemia, 2017-10, Vol.31 (10), p.2247-2251

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia

Leukemia, 2012-07, Vol.26 (7), p.1475-1481

2012

Link zum Volltext

Verfügbarkeit prüfen

The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia

Leukemia, 2011-04, Vol.25 (4), p.638-647

2011

Link zum Volltext

Verfügbarkeit prüfen

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia

Leukemia, 2005-05, Vol.19 (5), p.750-758

2005

Link zum Volltext

Verfügbarkeit prüfen

Functional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemia

Cell death discovery, 2016-01, Vol.2 (1), p.15070-15070, Article 15070

2016

Link zum Volltext

Verfügbarkeit prüfen

Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD‐1 inhibitors

Journal of the European Academy of Dermatology and Venereology, 2022-01, Vol.36 (S1), p.41-44

2022

Link zum Volltext

Verfügbarkeit prüfen

Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients

Blood advances, 2021-05, Vol.5 (9), p.2375-2384

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

Bone marrow transplantation (Basingstoke), 2017-02, Vol.52 (2), p.216-221

2017

Link zum Volltext

Verfügbarkeit prüfen

Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells

Cell death discovery, 2016-05, Vol.2 (1), p.16010-16010, Article 16010

2016

Link zum Volltext

Verfügbarkeit prüfen

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia

Leukemia, 2003-12, Vol.17 (12), p.2426-2434

2003

Link zum Volltext

Verfügbarkeit prüfen

Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation

Leukemia, 2012-09, Vol.26 (9), p.2039-2051

2012

Link zum Volltext

Verfügbarkeit prüfen

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia

Leukemia, 2002, Vol.16 (1), p.30-35

2002

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2022-06, Vol.22 (6), p.382-392

2022

Link zum Volltext

Verfügbarkeit prüfen

Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)

Leukemia, 2007-10, Vol.21 (10), p.2153-2163

2007

Link zum Volltext

Verfügbarkeit prüfen

Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients

Annals of oncology, 2012-04, Vol.23 (4), p.990-996

2012

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of chemokine receptors in B cell malignancies

Leukemia, 2001-05, Vol.15 (5), p.752-756

2001

Link zum Volltext

Verfügbarkeit prüfen

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status

Leukemia, 2006-10, Vol.20 (10), p.1774-1782

2006

Link zum Volltext

Verfügbarkeit prüfen

CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial

Annals of hematology, 2013-11, Vol.92 (11), p.1521-1528

2013

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells

Leukemia research, 2008-10, Vol.32 (10), p.1565-1572

2008

Link zum Volltext

Verfügbarkeit prüfen

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

Leukemia, 2013-10, Vol.27 (10), p.2102-2105

2013

Link zum Volltext

Verfügbarkeit prüfen

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin’s lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

Annals of oncology, 2008-03, Vol.19 (3), p.545-552

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Englisch
(165)
Deutsch
(31)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Humans
(120)
Life Sciences & Biomedicine
(120)
Female
(73)
Hematology
(72)
Male
(70)
Biological And Medical Sciences
(64)
Medical Sciences
(55)
Middle Aged
(55)
Oncology
(41)
Adult
(40)
Aged
(39)
Hematologic And Hematopoietic Diseases
(35)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(33)
Animals
(30)
Prognosis
(25)
Leukemia
(23)
Mice
(22)
Flow Cytometry
(17)
Chemotherapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia
(26)
Blood
(21)
Deutsche Medizinische Wochenschrift
(17)
Annals Of Hematology
(10)
British Journal Of Haematology
(9)
European Journal Of Haematology
(6)
Leukemia Research
(6)
Annals Of Oncology
(5)
American Journal Of Transplantation
(4)
Der Internist
(4)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma

Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia

The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia

Functional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemia

Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia: divergent outcomes in two men treated with PD‐1 inhibitors

Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia

Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia

Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma

Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)

Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients

Differential expression of chemokine receptors in B cell malignancies

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status

CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial

Bone marrow fibroblasts induce expression of PI3K/NF-κB pathway genes and a pro-angiogenic phenotype in CLL cells

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

Dose-escalated CHOEP for the treatment of young patients with aggressive non-Hodgkin’s lymphoma: II. Results of the randomized high-CHOEP trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)

S125: 10‐DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3 + 7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP, GIMEMA, CELG, AND GMDS‐SG

Suchergebnisse filtern